世界のエノキサパリンナトリウム注射市場インサイト・予測(~2027)

QYResearchが発行した調査報告書(QY21AUG4056)
◆英語タイトル:Global Enoxaparin Sodium Injection Market Insights and Forecast to 2027
◆商品コード:QY21AUG4056
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年8月
◆ページ数:125
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥661,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥992,250見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,323,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはエノキサパリンナトリウム注射の世界市場の現状について調査・分析し、2027年までの市場を予測しました。エノキサパリンナトリウム注射の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(20 mg/0.2mL、30 mg/0.3mL、40 mg/0.4mL、60 mg/0.6mL、80 mg/0.8mL、100 mg/1mL、120 mg/0.8mL、150 mg/1mL、300mg/3mL)、用途別市場規模(病院、クリニック、その他)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・エノキサパリンナトリウム注射の世界市場概要
・メーカー別の競争状況、市場シェア
・エノキサパリンナトリウム注射の種類別市場規模:20 mg/0.2mL、30 mg/0.3mL、40 mg/0.4mL、60 mg/0.6mL、80 mg/0.8mL、100 mg/1mL、120 mg/0.8mL、150 mg/1mL、300mg/3mL
・エノキサパリンナトリウム注射の用途別市場規模:病院、クリニック、その他
・北米のエノキサパリンナトリウム注射市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパのエノキサパリンナトリウム注射市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアのエノキサパリンナトリウム注射市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米のエノキサパリンナトリウム注射市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカのエノキサパリンナトリウム注射市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:Sanofi、Fresenius Kabi、Rovi、Amphastar、Teva、Nanjing King-friend、Techdow (Hepalink)、Sandoz、Apotex、Cipla、Taj Pharma、Hangzhou Jiuyuan Gene Engineering、Chengdu Baiyu Pharmaceutical、Hebei Changshan Biochemical Pharmaceutical、Changzhou Qianhong Bio-pharma、Beijing SL Pharmaceutical、Suzhou Erye Pharmaceutical
・エノキサパリンナトリウム注射のバリューチェーン・販売チャネル分析
・エノキサパリンナトリウム注射の世界市場動向
【レポートの概要】

Market Analysis and Insights: Global Enoxaparin Sodium Injection Market
The global Enoxaparin Sodium Injection market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Enoxaparin Sodium Injection Scope and Segment
Enoxaparin Sodium Injection market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Enoxaparin Sodium Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
20 mg/0.2mL
30 mg/0.3mL
40 mg/0.4mL
60 mg/0.6mL
80 mg/0.8mL
100 mg/1mL
120 mg/0.8mL
150 mg/1mL
300mg/3mL

Segment by Application
Hospital
Clinic
Others

By Company
Sanofi
Fresenius Kabi
Rovi
Amphastar
Teva
Nanjing King-friend
Techdow (Hepalink)
Sandoz
Apotex
Cipla
Taj Pharma
Hangzhou Jiuyuan Gene Engineering
Chengdu Baiyu Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Changzhou Qianhong Bio-pharma
Beijing SL Pharmaceutical
Suzhou Erye Pharmaceutical

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

【レポートの目次】

1 Study Coverage
1.1 Enoxaparin Sodium Injection Product Introduction
1.2 Market by Type
1.2.1 Global Enoxaparin Sodium Injection Market Size Growth Rate by Type
1.2.2 20 mg/0.2mL
1.2.3 30 mg/0.3mL
1.2.4 40 mg/0.4mL
1.2.5 60 mg/0.6mL
1.2.6 80 mg/0.8mL
1.2.7 100 mg/1mL
1.2.8 120 mg/0.8mL
1.2.9 150 mg/1mL
1.2.10 300mg/3mL
1.3 Market by Application
1.3.1 Global Enoxaparin Sodium Injection Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Enoxaparin Sodium Injection Sales Estimates and Forecasts 2016-2027
2.2 Global Enoxaparin Sodium Injection Revenue Estimates and Forecasts 2016-2027
2.3 Global Enoxaparin Sodium Injection Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Enoxaparin Sodium Injection Regions by Sales
2.4.1 Global Top Enoxaparin Sodium Injection Regions by Sales (2016-2021)
2.4.2 Global Top Enoxaparin Sodium Injection Regions by Sales (2022-2027)
2.5 Global Top Enoxaparin Sodium Injection Regions by Revenue
2.5.1 Global Top Enoxaparin Sodium Injection Regions by Revenue (2016-2021)
2.5.2 Global Top Enoxaparin Sodium Injection Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Enoxaparin Sodium Injection Sales by Manufacturers
3.1.1 Global Top Enoxaparin Sodium Injection Manufacturers by Sales (2016-2021)
3.1.2 Global Top Enoxaparin Sodium Injection Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Enoxaparin Sodium Injection Sales in 2020
3.2 Global Enoxaparin Sodium Injection Revenue by Manufacturers
3.2.1 Global Top Enoxaparin Sodium Injection Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Enoxaparin Sodium Injection Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Enoxaparin Sodium Injection Revenue in 2020
3.3 Global Enoxaparin Sodium Injection Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Enoxaparin Sodium Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Enoxaparin Sodium Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Enoxaparin Sodium Injection Sales by Type
4.1.1 Global Enoxaparin Sodium Injection Historical Sales by Type (2016-2021)
4.1.2 Global Enoxaparin Sodium Injection Forecasted Sales by Type (2022-2027)
4.1.3 Global Enoxaparin Sodium Injection Sales Market Share by Type (2016-2027)
4.2 Global Enoxaparin Sodium Injection Revenue by Type
4.2.1 Global Enoxaparin Sodium Injection Historical Revenue by Type (2016-2021)
4.2.2 Global Enoxaparin Sodium Injection Forecasted Revenue by Type (2022-2027)
4.2.3 Global Enoxaparin Sodium Injection Revenue Market Share by Type (2016-2027)
4.3 Global Enoxaparin Sodium Injection Price by Type
4.3.1 Global Enoxaparin Sodium Injection Price by Type (2016-2021)
4.3.2 Global Enoxaparin Sodium Injection Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Enoxaparin Sodium Injection Sales by Application
5.1.1 Global Enoxaparin Sodium Injection Historical Sales by Application (2016-2021)
5.1.2 Global Enoxaparin Sodium Injection Forecasted Sales by Application (2022-2027)
5.1.3 Global Enoxaparin Sodium Injection Sales Market Share by Application (2016-2027)
5.2 Global Enoxaparin Sodium Injection Revenue by Application
5.2.1 Global Enoxaparin Sodium Injection Historical Revenue by Application (2016-2021)
5.2.2 Global Enoxaparin Sodium Injection Forecasted Revenue by Application (2022-2027)
5.2.3 Global Enoxaparin Sodium Injection Revenue Market Share by Application (2016-2027)
5.3 Global Enoxaparin Sodium Injection Price by Application
5.3.1 Global Enoxaparin Sodium Injection Price by Application (2016-2021)
5.3.2 Global Enoxaparin Sodium Injection Price Forecast by Application (2022-2027)

6 North America
6.1 North America Enoxaparin Sodium Injection Market Size by Type
6.1.1 North America Enoxaparin Sodium Injection Sales by Type (2016-2027)
6.1.2 North America Enoxaparin Sodium Injection Revenue by Type (2016-2027)
6.2 North America Enoxaparin Sodium Injection Market Size by Application
6.2.1 North America Enoxaparin Sodium Injection Sales by Application (2016-2027)
6.2.2 North America Enoxaparin Sodium Injection Revenue by Application (2016-2027)
6.3 North America Enoxaparin Sodium Injection Market Size by Country
6.3.1 North America Enoxaparin Sodium Injection Sales by Country (2016-2027)
6.3.2 North America Enoxaparin Sodium Injection Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Enoxaparin Sodium Injection Market Size by Type
7.1.1 Europe Enoxaparin Sodium Injection Sales by Type (2016-2027)
7.1.2 Europe Enoxaparin Sodium Injection Revenue by Type (2016-2027)
7.2 Europe Enoxaparin Sodium Injection Market Size by Application
7.2.1 Europe Enoxaparin Sodium Injection Sales by Application (2016-2027)
7.2.2 Europe Enoxaparin Sodium Injection Revenue by Application (2016-2027)
7.3 Europe Enoxaparin Sodium Injection Market Size by Country
7.3.1 Europe Enoxaparin Sodium Injection Sales by Country (2016-2027)
7.3.2 Europe Enoxaparin Sodium Injection Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Enoxaparin Sodium Injection Market Size by Type
8.1.1 Asia Pacific Enoxaparin Sodium Injection Sales by Type (2016-2027)
8.1.2 Asia Pacific Enoxaparin Sodium Injection Revenue by Type (2016-2027)
8.2 Asia Pacific Enoxaparin Sodium Injection Market Size by Application
8.2.1 Asia Pacific Enoxaparin Sodium Injection Sales by Application (2016-2027)
8.2.2 Asia Pacific Enoxaparin Sodium Injection Revenue by Application (2016-2027)
8.3 Asia Pacific Enoxaparin Sodium Injection Market Size by Region
8.3.1 Asia Pacific Enoxaparin Sodium Injection Sales by Region (2016-2027)
8.3.2 Asia Pacific Enoxaparin Sodium Injection Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Enoxaparin Sodium Injection Market Size by Type
9.1.1 Latin America Enoxaparin Sodium Injection Sales by Type (2016-2027)
9.1.2 Latin America Enoxaparin Sodium Injection Revenue by Type (2016-2027)
9.2 Latin America Enoxaparin Sodium Injection Market Size by Application
9.2.1 Latin America Enoxaparin Sodium Injection Sales by Application (2016-2027)
9.2.2 Latin America Enoxaparin Sodium Injection Revenue by Application (2016-2027)
9.3 Latin America Enoxaparin Sodium Injection Market Size by Country
9.3.1 Latin America Enoxaparin Sodium Injection Sales by Country (2016-2027)
9.3.2 Latin America Enoxaparin Sodium Injection Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia

10 Middle East and Africa
10.1 Middle East and Africa Enoxaparin Sodium Injection Market Size by Type
10.1.1 Middle East and Africa Enoxaparin Sodium Injection Sales by Type (2016-2027)
10.1.2 Middle East and Africa Enoxaparin Sodium Injection Revenue by Type (2016-2027)
10.2 Middle East and Africa Enoxaparin Sodium Injection Market Size by Application
10.2.1 Middle East and Africa Enoxaparin Sodium Injection Sales by Application (2016-2027)
10.2.2 Middle East and Africa Enoxaparin Sodium Injection Revenue by Application (2016-2027)
10.3 Middle East and Africa Enoxaparin Sodium Injection Market Size by Country
10.3.1 Middle East and Africa Enoxaparin Sodium Injection Sales by Country (2016-2027)
10.3.2 Middle East and Africa Enoxaparin Sodium Injection Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Sanofi Enoxaparin Sodium Injection Product Description
11.1.5 Sanofi Recent Developments
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Corporation Information
11.2.2 Fresenius Kabi Overview
11.2.3 Fresenius Kabi Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Fresenius Kabi Enoxaparin Sodium Injection Product Description
11.2.5 Fresenius Kabi Recent Developments
11.3 Rovi
11.3.1 Rovi Corporation Information
11.3.2 Rovi Overview
11.3.3 Rovi Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Rovi Enoxaparin Sodium Injection Product Description
11.3.5 Rovi Recent Developments
11.4 Amphastar
11.4.1 Amphastar Corporation Information
11.4.2 Amphastar Overview
11.4.3 Amphastar Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Amphastar Enoxaparin Sodium Injection Product Description
11.4.5 Amphastar Recent Developments
11.5 Teva
11.5.1 Teva Corporation Information
11.5.2 Teva Overview
11.5.3 Teva Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Teva Enoxaparin Sodium Injection Product Description
11.5.5 Teva Recent Developments
11.6 Nanjing King-friend
11.6.1 Nanjing King-friend Corporation Information
11.6.2 Nanjing King-friend Overview
11.6.3 Nanjing King-friend Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Nanjing King-friend Enoxaparin Sodium Injection Product Description
11.6.5 Nanjing King-friend Recent Developments
11.7 Techdow (Hepalink)
11.7.1 Techdow (Hepalink) Corporation Information
11.7.2 Techdow (Hepalink) Overview
11.7.3 Techdow (Hepalink) Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Techdow (Hepalink) Enoxaparin Sodium Injection Product Description
11.7.5 Techdow (Hepalink) Recent Developments
11.8 Sandoz
11.8.1 Sandoz Corporation Information
11.8.2 Sandoz Overview
11.8.3 Sandoz Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Sandoz Enoxaparin Sodium Injection Product Description
11.8.5 Sandoz Recent Developments
11.9 Apotex
11.9.1 Apotex Corporation Information
11.9.2 Apotex Overview
11.9.3 Apotex Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Apotex Enoxaparin Sodium Injection Product Description
11.9.5 Apotex Recent Developments
11.10 Cipla
11.10.1 Cipla Corporation Information
11.10.2 Cipla Overview
11.10.3 Cipla Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Cipla Enoxaparin Sodium Injection Product Description
11.10.5 Cipla Recent Developments
11.11 Taj Pharma
11.11.1 Taj Pharma Corporation Information
11.11.2 Taj Pharma Overview
11.11.3 Taj Pharma Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 Taj Pharma Enoxaparin Sodium Injection Product Description
11.11.5 Taj Pharma Recent Developments
11.12 Hangzhou Jiuyuan Gene Engineering
11.12.1 Hangzhou Jiuyuan Gene Engineering Corporation Information
11.12.2 Hangzhou Jiuyuan Gene Engineering Overview
11.12.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Product Description
11.12.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
11.13 Chengdu Baiyu Pharmaceutical
11.13.1 Chengdu Baiyu Pharmaceutical Corporation Information
11.13.2 Chengdu Baiyu Pharmaceutical Overview
11.13.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Product Description
11.13.5 Chengdu Baiyu Pharmaceutical Recent Developments
11.14 Hebei Changshan Biochemical Pharmaceutical
11.14.1 Hebei Changshan Biochemical Pharmaceutical Corporation Information
11.14.2 Hebei Changshan Biochemical Pharmaceutical Overview
11.14.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Product Description
11.14.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
11.15 Changzhou Qianhong Bio-pharma
11.15.1 Changzhou Qianhong Bio-pharma Corporation Information
11.15.2 Changzhou Qianhong Bio-pharma Overview
11.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Product Description
11.15.5 Changzhou Qianhong Bio-pharma Recent Developments
11.16 Beijing SL Pharmaceutical
11.16.1 Beijing SL Pharmaceutical Corporation Information
11.16.2 Beijing SL Pharmaceutical Overview
11.16.3 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.16.4 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Product Description
11.16.5 Beijing SL Pharmaceutical Recent Developments
11.17 Suzhou Erye Pharmaceutical
11.17.1 Suzhou Erye Pharmaceutical Corporation Information
11.17.2 Suzhou Erye Pharmaceutical Overview
11.17.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.17.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Product Description
11.17.5 Suzhou Erye Pharmaceutical Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Enoxaparin Sodium Injection Value Chain Analysis
12.2 Enoxaparin Sodium Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Enoxaparin Sodium Injection Production Mode & Process
12.4 Enoxaparin Sodium Injection Sales and Marketing
12.4.1 Enoxaparin Sodium Injection Sales Channels
12.4.2 Enoxaparin Sodium Injection Distributors
12.5 Enoxaparin Sodium Injection Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Enoxaparin Sodium Injection Industry Trends
13.2 Enoxaparin Sodium Injection Market Drivers
13.3 Enoxaparin Sodium Injection Market Challenges
13.4 Enoxaparin Sodium Injection Market Restraints

14 Key Findings in The Global Enoxaparin Sodium Injection Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Sanofi、Fresenius Kabi、Rovi、Amphastar、Teva、Nanjing King-friend、Techdow (Hepalink)、Sandoz、Apotex、Cipla、Taj Pharma、Hangzhou Jiuyuan Gene Engineering、Chengdu Baiyu Pharmaceutical、Hebei Changshan Biochemical Pharmaceutical、Changzhou Qianhong Bio-pharma、Beijing SL Pharmaceutical、Suzhou Erye Pharmaceutical

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のエノキサパリンナトリウム注射市場インサイト・予測(~2027)(Global Enoxaparin Sodium Injection Market Insights and Forecast to 2027)]についてメールでお問い合わせはこちらでお願いします。